7 recruiting. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 7 |
| Phase 1 | 3 | Recruiting 3 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Pitavastatin 1-4 mg daily, Rosuvastatin 20-40 mg daily - Erectile Dysfunction Due to Arterial Disease, Atheroscleroses | Phase 2 | Recruiting | Lomonosov Moscow State University Medical Research and Educational Center | 150 | 2026-03-05 | 2026-03-16 |
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD TB-500, Placebo - Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction | Phase 1 / Phase 2 | Recruiting | Hudson Biotech | 80 | 2026-02-05 | 2026-11-12 |
| Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure Iloprost, Isotonic saline - Acute Respiratory Failure, Endothelial Dysfunction | Phase 2 | Recruiting | Pär Johansson | 450 | 2024-04-15 | 2025-08-22 |
| Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes Dulaglutide, Placebo - Diabetes Mellitus, Type 1, Endothelial Dysfunction | Phase 2 | Recruiting | AdventHealth Translational Research Institute | 47 | 2023-10-05 | 2026-10-15 |
| Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals Ischemic Conditioning - Aging, Fragility | Phase 2 | Recruiting | Medical College of Wisconsin | 60 | 2023-05-02 | 2025-09-23 |
| Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain | Phase 1 / Phase 2 | Recruiting | University of Calgary | 12 | 2023-01-01 | 2026-05-01 |
| Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans Galantamine, Placebo, TENS 7000 - Endothelial Dysfunction | Phase 1 / Phase 2 | Recruiting | Vanderbilt University Medical Center | 160 | 2021-12-20 | 2026-05-18 |
Atherosclerosis (2) · Aneurysm (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 1 (1) · Erectile Dysfunction (1) · Hypoxia, Brain (1) · Inflammation (1) · Motor Activity (1) · Sleep Apnea Syndromes (1) · Sleep Wake Disorders (1) · Stroke (1)
Vascular Diseases (4) · Cardiovascular Diseases (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Mental Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Apnea (1) · Autoimmune Diseases (1) · Behavior (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Dyssomnias (1)
Cerebrovascular Circulation (1) · Core Binding Factors (1) · Galantamine (1) · Iloprost (1) · Rosuvastatin Calcium (1) · Sodium Chloride (1) · Sugars (1) · dulaglutide (1) · pitavastatin (1)
AdventHealth Translational Research Institute (1) · Hudson Biotech (1) · Lomonosov Moscow State University Medical Research and Educational Center (1) · Medical College of Wisconsin (1) · Pär Johansson (1) · University of Calgary (1) · Vanderbilt University Medical Center (1)
United States (3) · Canada (1) · China (1) · Denmark (1) · Russia (1)
Cyndya Shibao, MD (1) · Kaitlin Love, MD (1) · Peter Soee-Jensen, MD (1)
K23DK131327 (1)